Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Sanofi Pasteur Limited Plans Vaccine Manufacturing Complex in Toronto, Ontario

05/03/2018
Sanofi Pasteur Limited plans to open a $500-million project to establish one of the most advanced vaccine manufacturing facilities in the world at its complex in Toronto, Ontario, Canada.

The new 150,000-square-foot Bulk Biologics Facility, at the Connaught Campus in Toronto, will be the first of its kind. The company will double the output of its life-saving vaccines by 2023 and launch the Canadian researched and developed pertussis, or whooping cough, vaccine into over 30 new international markets, protecting children and families in Canada and all over the world.

Sanofi Pasteur is the vaccines division of Sanofi, one of the world's leading healthcare companies and vaccine manufacturers globally, and produces critical vaccines to prevent infectious diseases.The Bulk Biologics Facility is expected to be operational in 2023.

“Canada has a strong legacy in the research and development of vaccines. With this investment, Sanofi is renewing our longstanding commitment to making Canada central in our effort to protect and improve human health across the globe. Vaccines save three million lives every year and this new facility will take us one step closer to a world where no one suffers or dies from a vaccine-preventable disease,” said David Loew, President and Head of Sanofi Pasteur.

The FedDev Ontario contribution of $20 million is a repayable contribution through the Advanced Manufacturing Fund. The Government of Ontario is investing $50 million through the Jobs and Prosperity Fund.

“The Government of Canada is proud to support Canada’s life sciences sector and the adoption of new, innovative manufacturing technologies. This project with Sanofi Pasteur will mean well-paying, middle-class jobs for Canadians, but more importantly, it will protect and improve the health of our families and children. This is a real example of innovation investment improving the quality of life for Canadians, The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for the Federal Economic Development Agency for Southern Ontario said.

Exclusive Research